l carnitine deficiency in Chronic Kidney Disease: Pathophysiology, Clinical Implications, and Therapeutic Perspectives L-carnitine tartrate supplementation in the

2020ZFB010, and the Foundation of State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers (2025GTEP016)

Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses

Ann N Y Acad Sci 2004;1033:30-41

Emerging evidence suggests that ALC levels are reduced in individuals with MDD, and this deficiency may contribute to depressive symptoms through disruptions in mitochondrial fatty acid transport, neuroplasticity, and neurotransmission

These findings remain preliminary and should be interpreted cautiously, but they highlight the peptides complex regulatory effects on cellular biology

The good newsand there is someis that the effects appear to be both dose-dependent and reversible